Mira Pharmaceuticals (MIRA) Assets Average (2023 - 2025)
Mira Pharmaceuticals (MIRA) posted Assets Average of $9.4 million for Q4 2025, up 120.27% sequentially from $4.3 million in Q3 2025, and up 160.47% YoY from $3.6 million in Q4 2024.
Mira Pharmaceuticals (MIRA) Assets Average (2023 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 3 years of Assets Average data on file, last reported at $9.4 million in Q4 2025.
- Quarterly Assets Average rose 160.47% year-over-year to $9.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $9.4 million (up 160.47% YoY) and the FY2025 annual result came in at $7.0 million, up 78.43% from the prior year.
- Assets Average advanced to $9.4 million in Q4 2025 per MIRA's latest filing, from $4.3 million in the prior quarter.
- The five-year high for Assets Average was $9.4 million in Q4 2025, with the low at $1.1 million in Q2 2025.
- Average Assets Average over 3 years is $4.8 million, with a median of $4.3 million recorded in 2024.
- The widest YoY moves for Assets Average: up 160.47% in 2025, down 50.54% in 2025.
- Mira Pharmaceuticals' Assets Average stood at $7.0 million in 2023, then sank by 48.46% to $3.6 million in 2024, then surged by 160.47% to $9.4 million in 2025.
- Business Quant data shows MIRA's Assets Average at $9.4 million in Q4 2025, $4.3 million in Q3 2025, and $1.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 114.53 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 200.05 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 135.21 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 114.04 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 132.78 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 91.55 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 57.65 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 208.08 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | 9.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.36 Mn |
| Sep 30, 2025 | 4.25 Mn |
| Jun 30, 2025 | 1.13 Mn |
| Mar 31, 2025 | 2.16 Mn |
| Dec 31, 2024 | 3.59 Mn |
| Mar 31, 2024 | 4.37 Mn |
| Dec 31, 2023 | 6.98 Mn |
| Sep 30, 2023 | 6.42 Mn |